<p>(a) Increase in U87 cell proliferation rate in response to CXCL12. (b) Reduction of CXCL12 induced proliferation of U87 cells by antagonists after 3 days. </p
<p>(A) PANC-1, (B) Hs-766T, and (C) MIAPaCa-2 cells were pretreated with chloroquine or hydroxychlor...
<p>Note: The OD values present Mean ± SD from 3 independent experiments.</p><p>Effect of CCL21 on T2...
<p>Cell migration toward either RPMI with 0.1% BSA and RPMI or 0.1% BSA containing CXCL12 (200 ng/mL...
<p>Effect of antagonists on CXCL12 induced migration of U87 cells in a two chamber assay.</p
<p>A) Cell proliferation was examined by BrdU assay following 24–72 h treatment with CXCL8 in A549 (...
<p>Proliferation of Raji cells exposed to chemokine CXCL12 after 24, 48 and 72-assay. The mean optic...
<p>A, Incubation with LPS, SW480 cell line pretreated with AMD3100 (10 µg/ml) proliferated significa...
<p>A549 (A) and H460 (B) cells were treated with CCL21 (100 ng/mL) for 24, 48, or 72 h, and cell vit...
<p>(A) Quantification of CXCR7 expression by flow cytometry, in the total population of transfected ...
<p>IEC-6 cells were treated with LPS (2 µg/mL) for 48 hours in the presence or absence of A) Celecox...
<p>BEAS-2B cells were pretreated with inhibitor 1 h before stimulation with IL-17A (100 ng/mL) and/o...
<p><b>(A)</b> Cells were pretreated with inhibitors specific for JNK (SP600125), ERK1/2 (U0126), and...
<p>(A-D):48-h treatment with TM-025/TM-026 showed significant (P<0.0001; depicted with *) dose-depen...
<p>(A) Graphs illustrating cell count assay data, determined from the treatment of PC3 cells (left p...
<p>hUCB-MSCs were treated with various doses of Pam<sub>3</sub>CSK<sub>4</sub>, LPS (A), Tri-DAP, an...
<p>(A) PANC-1, (B) Hs-766T, and (C) MIAPaCa-2 cells were pretreated with chloroquine or hydroxychlor...
<p>Note: The OD values present Mean ± SD from 3 independent experiments.</p><p>Effect of CCL21 on T2...
<p>Cell migration toward either RPMI with 0.1% BSA and RPMI or 0.1% BSA containing CXCL12 (200 ng/mL...
<p>Effect of antagonists on CXCL12 induced migration of U87 cells in a two chamber assay.</p
<p>A) Cell proliferation was examined by BrdU assay following 24–72 h treatment with CXCL8 in A549 (...
<p>Proliferation of Raji cells exposed to chemokine CXCL12 after 24, 48 and 72-assay. The mean optic...
<p>A, Incubation with LPS, SW480 cell line pretreated with AMD3100 (10 µg/ml) proliferated significa...
<p>A549 (A) and H460 (B) cells were treated with CCL21 (100 ng/mL) for 24, 48, or 72 h, and cell vit...
<p>(A) Quantification of CXCR7 expression by flow cytometry, in the total population of transfected ...
<p>IEC-6 cells were treated with LPS (2 µg/mL) for 48 hours in the presence or absence of A) Celecox...
<p>BEAS-2B cells were pretreated with inhibitor 1 h before stimulation with IL-17A (100 ng/mL) and/o...
<p><b>(A)</b> Cells were pretreated with inhibitors specific for JNK (SP600125), ERK1/2 (U0126), and...
<p>(A-D):48-h treatment with TM-025/TM-026 showed significant (P<0.0001; depicted with *) dose-depen...
<p>(A) Graphs illustrating cell count assay data, determined from the treatment of PC3 cells (left p...
<p>hUCB-MSCs were treated with various doses of Pam<sub>3</sub>CSK<sub>4</sub>, LPS (A), Tri-DAP, an...
<p>(A) PANC-1, (B) Hs-766T, and (C) MIAPaCa-2 cells were pretreated with chloroquine or hydroxychlor...
<p>Note: The OD values present Mean ± SD from 3 independent experiments.</p><p>Effect of CCL21 on T2...
<p>Cell migration toward either RPMI with 0.1% BSA and RPMI or 0.1% BSA containing CXCL12 (200 ng/mL...
DOI
Add to ORKG